"Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
Descriptor ID |
D002986
|
MeSH Number(s) |
E05.318.760.250.500 N05.715.360.775.088.500 N06.850.520.450.250.250
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Clinical Trials as Topic".
This graph shows the total number of publications written about "Clinical Trials as Topic" by people in this website by year, and whether "Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 30 | 31 |
1995 | 5 | 20 | 25 |
1996 | 1 | 16 | 17 |
1997 | 0 | 27 | 27 |
1998 | 3 | 25 | 28 |
1999 | 5 | 25 | 30 |
2000 | 7 | 37 | 44 |
2001 | 4 | 49 | 53 |
2002 | 11 | 60 | 71 |
2003 | 9 | 89 | 98 |
2004 | 5 | 80 | 85 |
2005 | 14 | 71 | 85 |
2006 | 23 | 92 | 115 |
2007 | 21 | 93 | 114 |
2008 | 18 | 104 | 122 |
2009 | 25 | 105 | 130 |
2010 | 25 | 105 | 130 |
2011 | 27 | 104 | 131 |
2012 | 19 | 74 | 93 |
2013 | 20 | 67 | 87 |
2014 | 27 | 73 | 100 |
2015 | 26 | 72 | 98 |
2016 | 28 | 90 | 118 |
2017 | 20 | 76 | 96 |
2018 | 29 | 63 | 92 |
2019 | 27 | 57 | 84 |
2020 | 28 | 72 | 100 |
2021 | 19 | 54 | 73 |
2022 | 6 | 26 | 32 |
2023 | 5 | 24 | 29 |
2024 | 0 | 10 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Clinical Trials as Topic" by people in Profiles.
-
Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design. Cancer Treat Rev. 2024 Apr; 125:102703.
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin. Am J Ther. 2024 Mar-Apr 01; 31(2):e121-e132.
-
Lost in Translation: Failure of Preclinical Studies to Accurately Predict the Effect of Regional Analgesia on Cancer Recurrence. Anesthesiology. 2024 Mar 01; 140(3):361-374.
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD). Am J Ther. 2024 Mar-Apr 01; 31(2):e104-e111.
-
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy. Drug Saf. 2024 Apr; 47(4):321-332.
-
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease. J Am Heart Assoc. 2024 Feb 20; 13(4):e028957.
-
Toward standardization in bladder cancer clinical trials: Guidance from the SITC-IBCG expert panel. J Immunother Cancer. 2024 Feb 02; 12(2).
-
Locoregional Therapies in Immunologically "Cold" Tumors: Opportunities and Clinical Trial Design Considerations. J Vasc Interv Radiol. 2024 Feb; 35(2):198-202.
-
ClinicalOmicsDB: exploring molecular associations of oncology drug responses in clinical trials. Nucleic Acids Res. 2024 Jan 05; 52(D1):D1201-D1209.
-
Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network Registry. Circ Cardiovasc Qual Outcomes. 2024 01; 17(1):e010092.